Nilutamide
Back to searchMolecule Structure
Scientific Name
Nilutamide
Description of the Drug
Nilutamide is an antineoplastic hormone used to treat prostate cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00665
http://www.drugbank.ca/drugs/DB00665
Brand Name(s)
Anadron, Nilandron, Nilutamide
Company Owner(s)
Concordia Pharmaceuticals Inc, Ani Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Androgen Receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1871 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL12670 | |
| PharmGKB | PA450632 | |
| Human Metabolome Database | HMDB0014803 | |
| DrugBank | DB00665 | |
| PubChem: Thomson Pharma | 14850346 | |
| PubChem | 4493 | |
| Mcule | MCULE-3215206804 | |
| LINCS | LSM-2513 | |
| BindingDB | 50135912 | |
| EPA CompTox Dashboard | DTXSID3034165 | |
| DrugCentral | 1933 | |
| ChemicalBook | CB3278091 | |
| Guide to Pharmacology | 2864 | |
| rxnorm | NILUTAMIDE | NILANDRON |
| PubChem: Drugs of the Future | 12013485 | |
| KEGG Ligand | C08164 | |
| ChEBI | 7573 | |
| ZINC | ZINC000003874498 |
